Predict your next investment

Advisory
movenscapital.com

See what CB Insights has to offer

Investments

12

Funds

1

About Movens Capital

Movens Capital is a transaction advisory boutique helping clients raise expansion capital (equity, debt, or mezzanine), as well as advising in their M&A deals. Movens Capital's partners have participated in numerous transactions, playing various roles as advisors, venture capital, private equity, mutual, or fund-of-funds managers, as well as executives of investee companies. Diverse experience on both buy- and sell-side and long experience in the Polish capital market enables Movens to effectively identify unique investment opportunities and match attractive projects with investors seeking such assets.

Movens Capital Headquarter Location

Budynek Metropolitan Plac Piłsudskiego 2, 1. piętro

Warsaw, 00-073,

Poland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Movens Capital News

Doctor.One has raised €2.1 million. Movens Capital has reinvested in the startup

May 4, 2022

Movens Capital has reinvested in the startup By Doctor.One is a virtual clinic that allows doctors to create and run a private medical practice in a subscription model. The basis of the healthcare provided is online medical rounds, during which medics use chat or phone calls to respond to messages from their patients, or contact them to check the progress of treatment. Through the app, they can also schedule an in-person visit or order tests. In Doctor.One, doctors are the ones who invite the patients they want to care for. They have full control over the time they devote to them, as well as the scope and price of the subscription. The idea of Doctor.One was noticed by jurors of the Start-up Challenge 2022 competition accompanying the European Economic Congress, who awarded the company with the title of winner in the Health&Biotechnology category. – We have been on the market for less than six months and already Doctor.One is used by doctors of over 30 specialisations – from family medicine and paediatrics, through gynaecology and allergology, to endocrinology, haematology and neonatology. We have received positive feedback from both doctors and patients about our model of continuous health care based on a direct relationship with a trusted doctor. What’s more, our data shows that after just one month of working with us, some physicians’ revenues increase by as much as 20 percent while maintaining a similar number of working hours. By increasing the decision-making power of doctors in terms of the time they devote to patients and the form of contact, they are able to manage their precious time more effectively while providing continuity of care which is unique on the market – says Tomasz Rudolf, CEO of Doctor.One. The huge potential of Doctor.One has been recognized by a renowned Berlin-based VC fund AtlanticLabs which invests in companies at the pre-seed and seed stage. AtlanticLabs has so far invested in over 130 companies with global potential, including Soundcloud, Zenjob, Clue, Choco, GetYourGuide or Omio. – The pay-per-visit model of care is outdated and leads to poorer accessibility to healthcare services. Doctor.One’s unique approach enables patients to have a closer relationship with trusted physicians and increases the number of health services provided online or over the phone, thereby positively impacting system efficiency and patient convenience. We are excited to support the team in its mission to provide access to the app to patients around the world, explains Daniel Niemi, Director at AtlanticLabs. – Raised funds will allow us to start expansion into European markets. We are also planning further development of the application, so that it is as close as possible to the needs of doctors and patients, as well as to the realities of local health markets. In order to achieve our ambitions, we intend to double the size of our team by the end of the year – adds Maciej Malenda, co-founder and COO of Doctor.One. Currently, Doctor.One is expanding the application and therefore recruiting programmers. Jan Namedyński has recently joined the company as Chief Technology Officer. He was previously Head of Global Digital Innovation Lab at Avon and CTO at Spark &Mortar, the USP Group’s new business incubator. – In the near future we will launch a new feature in the application – family accounts, which is a response to the needs of mainly family doctors, pediatricians and geriatricians. Thanks to them one specialist will be able to take care of the whole family. We are also in the process of negotiating a permanent cooperation agreement with a network of laboratories, which will facilitate the process of issuing and processing referrals for tests,” says Jan Namedyński, CTO of Doctor.One. Data from the “Digital Health Global Market Report 2022” shows that the global digital health market was worth over $201 billion in 2021 and is projected to reach nearly $253 billion in 2022 at an average annual growth rate of 25.5 percent. (CARG). The authors of the report also predict that the market will grow at a rate of 24 percent. (CARG) annually, reaching a value of nearly $597 billion in 2026. In this article:

Movens Capital Investments

12 Investments

Movens Capital has made 12 investments. Their latest investment was in Nethansa as part of their Series A on March 3, 2022.

CBI Logo

Movens Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/1/2022

Series A

Nethansa

$4.42M

No

3

12/2/2021

Seed VC

Doctor.One

$0.5M

Yes

2

10/13/2021

Series A

Vue Storefront

$17.4M

No

Christian Bach, Creandum, Early Bird Medical, Evan You, Heini Zachariassen, Mathias Christensen, Paua Ventures, and Undisclosed Angel Investors

1

8/24/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

1/21/2021

Bridge

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/1/2022

12/2/2021

10/13/2021

8/24/2021

1/21/2021

Round

Series A

Seed VC

Series A

Seed VC

Bridge

Company

Nethansa

Doctor.One

Vue Storefront

Subscribe to see more

Subscribe to see more

Amount

$4.42M

$0.5M

$17.4M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Christian Bach, Creandum, Early Bird Medical, Evan You, Heini Zachariassen, Mathias Christensen, Paua Ventures, and Undisclosed Angel Investors

Sources

3

2

1

10

10

Movens Capital Fund History

1 Fund History

Movens Capital has 1 fund, including Movens Capital Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Movens Capital Fund I

2

Closing Date

Fund

Movens Capital Fund I

Fund Type

Status

Amount

Sources

2

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.